Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy
Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as…
Month: May 2022
Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan
TOKYO, May 10, 2022 – (JCN Newswire) – Eisai Co., Ltd. today announced that it…
Broad Homes Utilizes Intelligent Manufacturing System to Expand into Smart Buildings
HONG KONG, May 10, 2022 – (ACN Newswire) – Broad Homes and Tencent Cloud enter…
Trellix Accelerates Growth in First 100 Days
Company Leading the Extended Detection and Response (XDR) Market Transition News Highlights Trellix momentum continues…
Heliogen, Inc. to Reschedule Release of First Quarter 2022 Earnings Results and Conference Call
PASADENA, Calif.–(BUSINESS WIRE)–Heliogen, Inc. (“Heliogen”) (NYSE: HLGN), a leading provider of AI-enabled concentrated solar energy…
Samsung Electronics Introduces Industry’s First 512GB CXL Memory Module
Newly developed CXL memory packs 4x the memory capacity over the previous version, enabling a…
TraceSafe Announces Cease Trade Order and Provides Update To Shareholders on Status of Financial Statements
Expects to Complete the Annual Filing on or Before May 13 Vancouver, British Columbia–(Newsfile Corp….
AMAZON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amazon.com, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update
SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical…
Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results
Data from COVID-19 Phase II study and norovirus Phase IB study are expected in 2022…
Zynerba Pharmaceuticals Announces Podium Presentation at the International Society for Autism Research Annual Meeting
DEVON, Pa., May 09, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Biomea Fusion to Participate in Bank of America Securities 2022 Healthcare Conference
REDWOOD CITY, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a…
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
– Cash, cash equivalents and marketable securities totaled $192.1 million as of March 31, 2022,…
IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update
– Closing of Global Collaboration Agreement with Sanofi; $150 Million Upfront Payment to IGM –…
Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational Progress
Biologics License Application for B-VEC remains on track to file in the US in 2Q…
Longeveron Announces CEO Transition
-Geoff Green stepping down as CEO, effective June 1, 2022 -K. Chris Min, M.D., Ph.D.,…
Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update
— Company Continues to Advance Phase 2 Portion of the Ongoing Phase 1/2 Clinical Proof-of-Concept…
Design Therapeutics Highlights Clinical and Research Progress and Reports First Quarter 2022 Financial Results
Clinical Execution of Lead GeneTAC™ Molecule, DT-216, with Initiation of Phase 1 Trial for the…
Neoleukin Therapeutics Announces First Quarter 2022 Financial Results and Corporate Update
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Leading Centralized Exchange, AscendEX Lists Enjin Token ($ENJ) and Efinity Token ($EFI)
SINGAPORE, May 09, 2022 (GLOBE NEWSWIRE) — Today, AscendEX is excited to announce the forthcoming…